British man jailed for sex with funeral home corpse

Agencies

February 2, 2019

London, Feb 2: A burglar who had sex with a corpse in an English funeral home he broke into was jailed on Friday for six years.

A judge in the industrial city of Birmingham said Kasim Khuram's crime "offended all human sensibility".

The man was found to have been both drunk and high on artificial cannabis and PCP at the time.

The 23-year-old pleaded guilty during at an earlier hearing.

The judge said Khuram disturbed the three bodies and nine coffins during the break-in.

"You set about disturbing all nine of these bodies -- exactly what you did, and why, only you know," judge Melbourne Inman said during the sentencing.

Defence lawyer Joseph Keating said Khuram was "deeply sorry" for what he had done and that his actions were "out of character".

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments